The combined induction of apoptosis (such as through the use of BH3 mimetics) and necroptosis (such as through the use of RIPK1 inhibitors) has been shown to significantly enhance the mortality rate of melanoma cells [215]. The gene discussed is RIPK1; the disease is melanoma.